ArticleCell cycle (Georgetown, Tex.)2022

Circ_0014235 confers Gefitinib resistance and malignant behaviors in non-small cell lung cancer resistant to Gefitinib by governing the miR-146b-5p/YAP/PD-L1 pathway.

Rong Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.